To reduce the submission of redundant data for biocidal products already approved under K-BPR, the National Institute of Chemical Safety (NICS) in South Korea has issued industry guidelines outlining a simplified application process for approved biocidal products.

The simplified process is applicable to changes or updates in the following areas:

• Scope of use (types of facilities where the substance/product can be used, such as industrial, residential, or multipurpose facilities)
• User scope (type of users using the substance/product, such as industrial, experts, professionals, and general users)
• Effectiveness/efficacy

1. Changes in scope of use or user range

• Under the simplified process, companies only need to submit approval for changes in the "scope of use" and "user scope" of representative biocidal products.
• Approval related to the biocidal substances in these products is not required.
• The original approvals regarding use/user scope will not change during the amendment, and reapplication is not necessary.

2. Changes in effectiveness/efficacy

• For some products under the simplified process, data on the effectiveness/efficacy of representative products need only be submitted.
• Approval related to the biocidal substances in these products is not required.
• The original approvals regarding effectiveness/efficacy will not change during the amendment, and reapplication is not necessary.

3. Types of biocidal products applicable under the simplified process

The simplified K-BPR amendment approval process officially took effect on September 11, 2024, significantly easing the burden on businesses for updating biocidal products already approved under K-BPR. Additionally, when applying for changes in use/user scope or effectiveness/efficacy, companies must also inform other members of the consortium and downstream customers about the changes, and share the updated information with other consortium members.